melior discovery

About Us
Our Pipeline
Our Platform
Partnering with Us
News
Contact Us

Click here for the MLR-1023 non-confidential brochure          

melior melior discovery

Investor Info news & publications

 

Melior Pharmaceuticals Announces Positive Phase 2A Results in Type 2 Diabetes Study
Press Release
June 13, 2016
Download PDF »

melior

 

Melior Discovery Announces Spinout of Melior Pharmaceuticals II, LLC
Press Release
May 10, 2016
Download PDF »

melior

 

Melior Pharmaceuticals Achieves Partnership Milestone with Bukwang Pharmaceutical Co.
Press Release
March 15, 2016
Download PDF »

melior

Melior Discovery Receives Patent Approval from U.S. Patent and Trademark Office for
New Parkinson's Disease Drug Candidate

Press Release
June 10, 2015
Download PDF »

melior

Melior Pharmaceuticals Initiates Phase 2 Study with MLR-1023 for Type 2 Diabetes
Press Release
March 3, 2015
Download PDF »

melior

Melior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action
Press Release
December 11, 2014
Download PDF »

melior

Melior Pharmaceuticals Receives First Performance Milestone Payment from
Bukwang Pharmaceutical

Press Release
October 7, 2014
Download PDF »

melior

Melior Licenses Novel Diabetes Drug to Bukwang Pharmaceutical Co.
Press Release
December 4, 2013
Download PDF »

melior

Melior Announces Two Publications Describing New Therapeutic Opportunity
in Diabetes

Press Release
April 17, 2012
Download PDF »

melior

Melior Announces New Scientific Advisory Board Member Dr. John Amatruda, an Expert in the Field of Diabetes and Drug Development to Join Board
Press Release
November 8, 2011
Download PDF »

melior

Melior Receives Notice of Allowance for Method of Use Patent for Repositioned Drug Candidate MLR-1023
Press Release
June 8, 2010
Download PDF »

melior

Melior Announces IND Approval for Novel Diabetes Drug MLR1023
Website Article
March 16, 2009
Download PDF »

melior

Melior Signs Option Agreement with Pfizer
Website Article
January 1, 2008
Download PDF »

melior

Christopher Lipinski, PhD named in top ten most influential people in pharma;
Worldpharmaceuticals frontiers 2007 Edition pharma40

Website Article
April 9, 2007
Read article »

melior

View the Archive


Back to top of page

 

 
home